05.06.2016 18:52:51
|
DGAP-Ad hoc: STADA Arzneimittel
STADA Arzneimittel AG / Key word(s): Miscellaneous
05.06.2016 18:52
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Bad Vilbel, June 5, 2016 - The Supervisory Board of STADA Arzneimittel AG
has decided on a change at the company's helm at an extraordinary meeting
held today. Due to a serious, long-term illness, the previous Chief
Executive Officer Hartmut Retzlaff has to lay down his office with
immediate effect until further notice. His duties will be assumed by the
Executive Board members Helmut Kraft and Dr. Matthias Wiedenfels.
Furthermore, Dr. Matthias Wiedenfels has initially been appointed Chief
Executive Officer.
Additional information for analysts:
STADA Arzneimittel AG / Investor Relations / Stadastraße 2-18 / 61118 Bad
Vilbel - Germany /
Tel.: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-215 / E-mail:
ir@stada.de
Additional information for journalists: STADA Arzneimittel AG / Media Relations / Stadastraße 2-18 / 61118 Bad Vilbel - Germany / Tel.: +49 (0) 6101 603-165 / Fax: +49 (0) 6101 603-215 / E-mail: press@stada.de
Or visit us in the Internet at www.stada.com.
05.06.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap.de
--------------------------------------------------------------------------- Language: English Company: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany Phone: +49 (0)6101 603- 113 Fax: +49 (0)6101 603- 506 E-mail: communications@stada.de Internet: www.stada.de ISIN: DE0007251803, DE0007251845, WKN: 725180, 725184, Indices: MDAX Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart; Terminbörse EUREX End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!